In this time of fluctuating tariff talks, many are concerned about what it will cost us. When it comes to paying for ...

US President Donald Trump's decision to impose punitive tariffs of 145% for pharmaceutical imports from China,1 effective since April 10, 2025, will pose substantial challenges towards global health ...

Cordyceps Sunshine Biotech Holdings Co., Ltd.【C.S Group】 announced a major milestone in veterinary drug development at the ...

Merck & Co. will grow its U.S. manufacturing footprint with a $1 billion plant in Delaware, becoming the latest drugmaker to ...

The areas most likely to see an impact among medical equipment include medical imaging devices, diagnostic equipment, ...

AstraZeneca ( AZN) CEO Pascal Soriot is not overly concerned about the threat of tariffs by the Trump administration on ...

PCI Pharma Services announced plans to acquire Ajinomoto Althea, Inc., a San Diego-based contract development and manufacturing organization (CDMO) specializing in sterile fill-finish services. The ...

The company CEO said he’s had “productive discussions” with Trump administration officials on a recently launched trade probe ...

Vas Narasimhan said on Tuesday that if the U.S. adopts international drug pricing, all companies would have to “relook at ...

Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...

Among other things, Makary breaks some news here by stating, for the first time, that there will be no significant ...

Stealth BioTherapeutics had expected the FDA to respond on Tuesday to its marketing application for elamipretide to treat ...